Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-Hydroxy Tamoxifen Gel for Cyclical Mastalgia
NCT00272714Phase 2Completed
- Sponsor
- ASCEND Therapeutics US, LLC
- Start
- Mar 2003
- Primary completion
- Mar 2004
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial of afimoxifene in cyclical mastalgia (3 arms), sponsored by ASCEND Therapeutics US, LLC. Primary endpoint: Change in average pain Visual Analog Scale (VAS) scores for the seven worst pain scores within a cycle. Started Mar 2003; status: completed.
02
Drugs
afimoxifene
03
Conditions
cyclical mastalgia
Beyond the preview
Go deeper on NCT00272714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272714.